Po‐Han Chao
- Hepatology top 10%
- Liver physiology and pathology 3
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 4
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems 3
-
- RNA Interference and Gene Delivery 4
- Lipid Membrane Structure and Behavior 3
- Extracellular vesicles in disease 2
-
- Nanoplatforms for cancer theranostics 4
-
- Cancer Research and Treatments 2
Po‐Han Chao
16 papers receiving 423 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Hepatology 102
- Biomaterials 103
- Pharmaceutical Science 30
- Molecular Medicine 24
- Immunology 73
Countries citing papers authored by Po‐Han Chao
This map shows the geographic impact of Po‐Han Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Han Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Han Chao more than expected).
Fields of papers citing papers by Po‐Han Chao
This network shows the impact of papers produced by Po‐Han Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Han Chao. The network helps show where Po‐Han Chao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Po‐Han Chao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 6 | |
| 7 | 2023 | 18 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 5 | |
| 12 | 2021 | 39 | |
| 13 | 2021 | 10 | |
| 14 | 2021 | 19 | |
| 15 | Lipid-based nanoparticle technologies for liver targetingbreakdown → | 2020 | 201 |
| 16 | 2017 | 85 | |
| 17 | 2017 | 10 |
About Po‐Han Chao
Po‐Han Chao is a scholar working on Pharmaceutical Science, Hepatology, Biomaterials, Biotechnology and Otorhinolaryngology, having authored 17 papers that have together received 426 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (4 papers), Nanoplatforms for cancer theranostics (4 papers), Liver physiology and pathology (3 papers), Lipid Membrane Structure and Behavior (3 papers), Advanced Drug Delivery Systems (3 papers), Extracellular vesicles in disease (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Hepatology (102 citations), Biomaterials (103 citations), Pharmaceutical Science (30 citations), Molecular Medicine (24 citations) and Immunology (73 citations). Po‐Han Chao has collaborated with scholars based in Canada, Taiwan and Germany. Frequent co-authors include Shyh‐Dar Li, Roland Böttger, Nojoud AL Fayez, Griffin Pauli, Hui‐Teng Cheng, Yunching Chen, Jane Wang, Yun‐Chieh Sung, Dongyu Gao and Chih-Chun Chang. Their work appears in journals such as Biomaterials, Journal of Controlled Release, Molecular Pharmaceutics, Journal of drug targeting and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.